Search

3:05 PM - 3:10 PM PT

1018 - Quantification and Qualification of Breast Cancer Patient Navigation From the Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial

Speaker: McClelland, Shearwood, MD - University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK

3:10 PM - 3:15 PM PT

1019 - Addressing Follow-Up Gaps in Prostate Cancer Survivorship Care: A Nurse-Led Pilot Program in a Developing Country

Speaker: Bettoli, Piero, MD - Universidad de Los Andes, LAS CONDES, Región Metropoli

2:50 PM - 3:00 PM PT

102 - Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases: A Phase 2 Randomized Controlled Trial (ATHENA Trial)

Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH

3:15 PM - 3:20 PM PT

1020 - Developing Patient-Facing Guidelines for Navigating Anal Sexual Health during and after Anal or Rectal Cancer Treatment

Speaker: Thompson, Petria, MD, PhD - University of California San Francisco, San Francisco, CA

3:20 PM - 3:25 PM PT

1021 - Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Clinical Entrustable Professional Activities

Speaker: Wagner, Brett - Rush University Medical Center, Chicago, IL

3:25 PM - 3:30 PM PT

1022 - Evaluating an Interactive Online Contouring Education Platform for Radiation Oncology Residents: Results of an International Longitudinal Randomized Controlled Trial

Speaker: Orr, Megan, MD - UCSD Health, La Jolla, CA

3:30 PM - 3:35 PM PT

1023 - Experimental Index Fund Investment vs. Historical NIH Grant Application Strategy to Fund Clinical Radiation Oncology Research

Speaker: Zaorsky, Nicholas, MD, MS - University Hospitals, Cleveland, Ohio

5:05 PM - 5:10 PM PT

1024 - Phase I Study of Hypofractionated Whole Pelvis Radiation in Endometrial Cancer Using a Novel Patient-Reported Outcomes Continual Reassessment Method (PRO-CRM)

Speaker: Feldkamp, Sarah, MD - University of Cincinnati, Cincinnati, OH

5:10 PM - 5:15 PM PT

1025 - Clinicopathologic and Molecular Heterogeneity of Aggressive Endometrial Carcinoma in the 2023 FIGO Staging System: A Dual-Cohort Retrospective and Prospective Analysis

Speaker: Ren, Kang, PhD - Peking Union Medical College Hospital, Beijing, Beijing

5:15 PM - 5:20 PM PT

1026 - Multi-Institutional Phase I Results from RT-PACE: Phase I/II Study of Adjuvant Whole Pelvic Hypofractionated Radiotherapy for Non-Metastatic Cervical and Endometrial Cancer

Speaker: Son, Christina, MD - University of Chicago Medicine, Chicago, IL

5:20 PM - 5:25 PM PT

1027 - Recurrence Pattern in Women with 2023 FIGO Stage IIC Endometrial Carcinoma with Negative Nodal Evaluation and Adjuvant Therapies

Speaker: Ghanem, Ahmed, MD, PhD - Henry Ford Cancer Institute/Alexandria University, Detroit, MI

5:25 PM - 5:30 PM PT

1028 - Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated with Definitive Chemoradiation and MRI-Guided Brachytherapy

Speaker: Gulstene, Stephanie, MD - London Regional Health Sciences, London, ON